Nicardipine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nicardipine Hydrochloride
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Nicardipine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 14 USDMF, 1 JDMF, 2 EU WC, 2 KDMF, 7 NDC API, 18 Listed Suppliers, $ API Reference Price

30 API Suppliers
14 USDMF
1 JDMF
2 EU WC
2 KDMF
7 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

61 FDF Dossiers, 45 FDA Orange Book, 6 Europe, 10 Listed Dossiers

61 FDF Dossiers
45 FDA Orange Book
6 Europe
10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)
INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 3 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 26 Coating Systems & Additives, 23 Direct Compression, 17 Thickeners and Stabilizers, 15 Controlled & Modified Release, 14 Taste Masking, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Film Formers & Plasticizers, 11 Granulation, 9 Disintegrants & Superdisintegrants, 8 Empty Capsules, 7 Chewable & Orodispersible Aids, 7 Parenteral, 5 Solubilizers, 4 Emulsifying Agents, 4 Topical, 3 Coloring Agents, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

43 Fillers, Diluents & Binders
26 Coating Systems & Additives
23 Direct Compression
17 Thickeners and Stabilizers
15 Controlled & Modified Release
14 Taste Masking
13 Lubricants & Glidants
13 Co-Processed Excipients
12 Film Formers & Plasticizers
11 Granulation
9 Disintegrants & Superdisintegrants
8 Empty Capsules
7 Chewable & Orodispersible Aids
7 Parenteral
5 Solubilizers
4 Emulsifying Agents
4 Topical
3 Coloring Agents
1 Soft Gelatin
1 API Stability Enhancers
1 Surfactant & Foaming Agents
1 Rheology Modifiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 Finished Drug Prices

7 Finished Drug Prices

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 5 Health Canada Patents

22 US Patents
2 US Exclusivities
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 Others

1 EDQM
1 USP
4 Others

$ API Ref.Price (USD/KG) : 10,358 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

22 All

01 22CHIESI

filter Patent Number Reset all filters

22 All

01 47612102

02 47659291

03 48455524

04 49364564

05 310758616

06 311547758

filter API Patent Reset all filters

22 All

01 22Blank

filter FDF Patent Reset all filters

22 All

01 11Y

02 11Blank

filter Expiration Date Reset all filters

22 All

01 142027-04-18

02 82027-12-26

Product Main Page

01

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 8455524

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 8455524

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 7659291

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 7659291

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 8455524

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 7659291

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 11547758

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 11547758

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 11547758

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

CHIESI

NICARDIPINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

CHIESI

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-04-18

NICARDIPINE HYDROCHLORIDE

US Patent Number : 8455524

Drug Substance Claim :

Drug Product Claim :

Application Number : 19734

Patent Use Code : U-1029

Delist Requested :

Patent Use Description : METHOD FOR TREATING AC...

Patent Expiration Date : 2027-04-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?